 Print View Attached Docs: |
|||||||||
| 94415:HLA B5701 TYPING | |||||||||
| Alias Names: | HLA-B5701 / HLA B*5701 / HLA-B*5701 | ||||||||
| Methodology: | Polymerase Chain Reaction (PCR) followed by Hybridization with Sequence Specific Oligonucleotide Probes (SSO) | ||||||||
| Edit Date: | 4/13/2009 | ||||||||
| Performed: | Monday-Friday | ||||||||
| Released: | 8-10 days after setup at PeaceHealth Laboratories’ reference lab. | ||||||||
| CPT Code: | 83891-90 / 83896-90 x30 / 83900-90 / 83912-90 | ||||||||
| Specimen Collection Details | |||||||||
| Collection: | One 10 mL yellow top tube (ACD solution A). Also acceptable: Yellow top tube (ACD solution B) or lavender top tube (EDTA). | ||||||||
| Handling: | Submit as whole blood. Do not spin. | ||||||||
| Stability: | 7 days ambient or 7 days refrigerated. Unstable frozen. | ||||||||
| Standard Volume: | 10 mL whole blood. | ||||||||
| Minimum Volume: | 3 mL whole blood. | ||||||||
| Transport: | Refrigerated. | ||||||||
| Comments: | HLA-B*5701 has been shown in retrospective clinical studies to be associated with Abacavir hypersensitivity reaction (HSR) in HIV patients. HLA-B*5701 genotyping may be useful for risk stratification. | ||||||||
| Rejection Criteria: | Frozen specimen; use of heparin tube.
This test may require insurance company prior authorization before ordering.
Please check the prior authorization list . Failure to gain preauthorization may result in denial of coverage. |
||||||||